The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anti-Tuberculosis Drug Market Research Report 2025
Synopsis
Tuberculosis is a chronic wasting infectious disease caused by Mycobacterium tuberculosis. The drugs used to treat this disease are anti-tuberculosis drugs.
The global Anti-Tuberculosis Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti-Tuberculosis Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Tuberculosis Drug.
Report Scope
The Anti-Tuberculosis Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Tuberculosis Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Tuberculosis Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lupin
Otsuka
Sanofi
Prizer
Abbott
NOVARTIS
Segment by Type
First-Line Anti-Tuberculosis Drugs
Second-Line Anti-Tuberculosis Drugs
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-Tuberculosis Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-Tuberculosis Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Tuberculosis is a chronic wasting infectious disease caused by Mycobacterium tuberculosis. The drugs used to treat this disease are anti-tuberculosis drugs.
The global Anti-Tuberculosis Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti-Tuberculosis Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Tuberculosis Drug.
Report Scope
The Anti-Tuberculosis Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Tuberculosis Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Tuberculosis Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lupin
Otsuka
Sanofi
Prizer
Abbott
NOVARTIS
Segment by Type
First-Line Anti-Tuberculosis Drugs
Second-Line Anti-Tuberculosis Drugs
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-Tuberculosis Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-Tuberculosis Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Anti-Tuberculosis Drug Market Overview
1.1 Product Overview and Scope of Anti-Tuberculosis Drug
1.2 Anti-Tuberculosis Drug Segment by Type
1.2.1 Global Anti-Tuberculosis Drug Market Value Comparison by Type (2024-2030)
1.2.2 First-Line Anti-Tuberculosis Drugs
1.2.3 Second-Line Anti-Tuberculosis Drugs
1.3 Anti-Tuberculosis Drug Segment by Application
1.3.1 Global Anti-Tuberculosis Drug Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Anti-Tuberculosis Drug Market Size Estimates and Forecasts
1.4.1 Global Anti-Tuberculosis Drug Revenue 2019-2030
1.4.2 Global Anti-Tuberculosis Drug Sales 2019-2030
1.4.3 Global Anti-Tuberculosis Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti-Tuberculosis Drug Market Competition by Manufacturers
2.1 Global Anti-Tuberculosis Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anti-Tuberculosis Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anti-Tuberculosis Drug Average Price by Manufacturers (2019-2024)
2.4 Global Anti-Tuberculosis Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-Tuberculosis Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Tuberculosis Drug, Product Type & Application
2.7 Anti-Tuberculosis Drug Market Competitive Situation and Trends
2.7.1 Anti-Tuberculosis Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-Tuberculosis Drug Players Market Share by Revenue
2.7.3 Global Anti-Tuberculosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Tuberculosis Drug Retrospective Market Scenario by Region
3.1 Global Anti-Tuberculosis Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti-Tuberculosis Drug Global Anti-Tuberculosis Drug Sales by Region: 2019-2030
3.2.1 Global Anti-Tuberculosis Drug Sales by Region: 2019-2024
3.2.2 Global Anti-Tuberculosis Drug Sales by Region: 2025-2030
3.3 Global Anti-Tuberculosis Drug Global Anti-Tuberculosis Drug Revenue by Region: 2019-2030
3.3.1 Global Anti-Tuberculosis Drug Revenue by Region: 2019-2024
3.3.2 Global Anti-Tuberculosis Drug Revenue by Region: 2025-2030
3.4 North America Anti-Tuberculosis Drug Market Facts & Figures by Country
3.4.1 North America Anti-Tuberculosis Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti-Tuberculosis Drug Sales by Country (2019-2030)
3.4.3 North America Anti-Tuberculosis Drug Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-Tuberculosis Drug Market Facts & Figures by Country
3.5.1 Europe Anti-Tuberculosis Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti-Tuberculosis Drug Sales by Country (2019-2030)
3.5.3 Europe Anti-Tuberculosis Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Tuberculosis Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-Tuberculosis Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti-Tuberculosis Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Anti-Tuberculosis Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Anti-Tuberculosis Drug Market Facts & Figures by Country
3.7.1 Latin America Anti-Tuberculosis Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti-Tuberculosis Drug Sales by Country (2019-2030)
3.7.3 Latin America Anti-Tuberculosis Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Tuberculosis Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Tuberculosis Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti-Tuberculosis Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti-Tuberculosis Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-Tuberculosis Drug Sales by Type (2019-2030)
4.1.1 Global Anti-Tuberculosis Drug Sales by Type (2019-2024)
4.1.2 Global Anti-Tuberculosis Drug Sales by Type (2025-2030)
4.1.3 Global Anti-Tuberculosis Drug Sales Market Share by Type (2019-2030)
4.2 Global Anti-Tuberculosis Drug Revenue by Type (2019-2030)
4.2.1 Global Anti-Tuberculosis Drug Revenue by Type (2019-2024)
4.2.2 Global Anti-Tuberculosis Drug Revenue by Type (2025-2030)
4.2.3 Global Anti-Tuberculosis Drug Revenue Market Share by Type (2019-2030)
4.3 Global Anti-Tuberculosis Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anti-Tuberculosis Drug Sales by Application (2019-2030)
5.1.1 Global Anti-Tuberculosis Drug Sales by Application (2019-2024)
5.1.2 Global Anti-Tuberculosis Drug Sales by Application (2025-2030)
5.1.3 Global Anti-Tuberculosis Drug Sales Market Share by Application (2019-2030)
5.2 Global Anti-Tuberculosis Drug Revenue by Application (2019-2030)
5.2.1 Global Anti-Tuberculosis Drug Revenue by Application (2019-2024)
5.2.2 Global Anti-Tuberculosis Drug Revenue by Application (2025-2030)
5.2.3 Global Anti-Tuberculosis Drug Revenue Market Share by Application (2019-2030)
5.3 Global Anti-Tuberculosis Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Lupin
6.1.1 Lupin Corporation Information
6.1.2 Lupin Description and Business Overview
6.1.3 Lupin Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Lupin Anti-Tuberculosis Drug Product Portfolio
6.1.5 Lupin Recent Developments/Updates
6.2 Otsuka
6.2.1 Otsuka Corporation Information
6.2.2 Otsuka Description and Business Overview
6.2.3 Otsuka Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Otsuka Anti-Tuberculosis Drug Product Portfolio
6.2.5 Otsuka Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi Anti-Tuberculosis Drug Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Prizer
6.4.1 Prizer Corporation Information
6.4.2 Prizer Description and Business Overview
6.4.3 Prizer Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Prizer Anti-Tuberculosis Drug Product Portfolio
6.4.5 Prizer Recent Developments/Updates
6.5 Abbott
6.5.1 Abbott Corporation Information
6.5.2 Abbott Description and Business Overview
6.5.3 Abbott Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Abbott Anti-Tuberculosis Drug Product Portfolio
6.5.5 Abbott Recent Developments/Updates
6.6 NOVARTIS
6.6.1 NOVARTIS Corporation Information
6.6.2 NOVARTIS Description and Business Overview
6.6.3 NOVARTIS Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 NOVARTIS Anti-Tuberculosis Drug Product Portfolio
6.6.5 NOVARTIS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Tuberculosis Drug Industry Chain Analysis
7.2 Anti-Tuberculosis Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Tuberculosis Drug Production Mode & Process
7.4 Anti-Tuberculosis Drug Sales and Marketing
7.4.1 Anti-Tuberculosis Drug Sales Channels
7.4.2 Anti-Tuberculosis Drug Distributors
7.5 Anti-Tuberculosis Drug Customers
8 Anti-Tuberculosis Drug Market Dynamics
8.1 Anti-Tuberculosis Drug Industry Trends
8.2 Anti-Tuberculosis Drug Market Drivers
8.3 Anti-Tuberculosis Drug Market Challenges
8.4 Anti-Tuberculosis Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Anti-Tuberculosis Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Anti-Tuberculosis Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Anti-Tuberculosis Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Anti-Tuberculosis Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Anti-Tuberculosis Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Anti-Tuberculosis Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Anti-Tuberculosis Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Anti-Tuberculosis Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Anti-Tuberculosis Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-Tuberculosis Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-Tuberculosis Drug, Product Type & Application
Table 12. Global Key Manufacturers of Anti-Tuberculosis Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-Tuberculosis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Tuberculosis Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-Tuberculosis Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Anti-Tuberculosis Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global Anti-Tuberculosis Drug Sales Market Share by Region (2019-2024)
Table 19. Global Anti-Tuberculosis Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global Anti-Tuberculosis Drug Sales Market Share by Region (2025-2030)
Table 21. Global Anti-Tuberculosis Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Anti-Tuberculosis Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Anti-Tuberculosis Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Anti-Tuberculosis Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Anti-Tuberculosis Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Anti-Tuberculosis Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America Anti-Tuberculosis Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America Anti-Tuberculosis Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Anti-Tuberculosis Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Anti-Tuberculosis Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Anti-Tuberculosis Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe Anti-Tuberculosis Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe Anti-Tuberculosis Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Anti-Tuberculosis Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Anti-Tuberculosis Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Anti-Tuberculosis Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Anti-Tuberculosis Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Anti-Tuberculosis Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Anti-Tuberculosis Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anti-Tuberculosis Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Anti-Tuberculosis Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Anti-Tuberculosis Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Anti-Tuberculosis Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Anti-Tuberculosis Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Anti-Tuberculosis Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Anti-Tuberculosis Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Anti-Tuberculosis Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Anti-Tuberculosis Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Anti-Tuberculosis Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Anti-Tuberculosis Drug Sales (K Units) by Type (2019-2024)
Table 51. Global Anti-Tuberculosis Drug Sales (K Units) by Type (2025-2030)
Table 52. Global Anti-Tuberculosis Drug Sales Market Share by Type (2019-2024)
Table 53. Global Anti-Tuberculosis Drug Sales Market Share by Type (2025-2030)
Table 54. Global Anti-Tuberculosis Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Anti-Tuberculosis Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Anti-Tuberculosis Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Anti-Tuberculosis Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Anti-Tuberculosis Drug Price (US$/Unit) by Type (2019-2024)
Table 59. Global Anti-Tuberculosis Drug Price (US$/Unit) by Type (2025-2030)
Table 60. Global Anti-Tuberculosis Drug Sales (K Units) by Application (2019-2024)
Table 61. Global Anti-Tuberculosis Drug Sales (K Units) by Application (2025-2030)
Table 62. Global Anti-Tuberculosis Drug Sales Market Share by Application (2019-2024)
Table 63. Global Anti-Tuberculosis Drug Sales Market Share by Application (2025-2030)
Table 64. Global Anti-Tuberculosis Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Anti-Tuberculosis Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Anti-Tuberculosis Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Anti-Tuberculosis Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Anti-Tuberculosis Drug Price (US$/Unit) by Application (2019-2024)
Table 69. Global Anti-Tuberculosis Drug Price (US$/Unit) by Application (2025-2030)
Table 70. Lupin Corporation Information
Table 71. Lupin Description and Business Overview
Table 72. Lupin Anti-Tuberculosis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Lupin Anti-Tuberculosis Drug Product
Table 74. Lupin Recent Developments/Updates
Table 75. Otsuka Corporation Information
Table 76. Otsuka Description and Business Overview
Table 77. Otsuka Anti-Tuberculosis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Otsuka Anti-Tuberculosis Drug Product
Table 79. Otsuka Recent Developments/Updates
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Anti-Tuberculosis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Sanofi Anti-Tuberculosis Drug Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Prizer Corporation Information
Table 86. Prizer Description and Business Overview
Table 87. Prizer Anti-Tuberculosis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Prizer Anti-Tuberculosis Drug Product
Table 89. Prizer Recent Developments/Updates
Table 90. Abbott Corporation Information
Table 91. Abbott Description and Business Overview
Table 92. Abbott Anti-Tuberculosis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Abbott Anti-Tuberculosis Drug Product
Table 94. Abbott Recent Developments/Updates
Table 95. NOVARTIS Corporation Information
Table 96. NOVARTIS Description and Business Overview
Table 97. NOVARTIS Anti-Tuberculosis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. NOVARTIS Anti-Tuberculosis Drug Product
Table 99. NOVARTIS Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Anti-Tuberculosis Drug Distributors List
Table 103. Anti-Tuberculosis Drug Customers List
Table 104. Anti-Tuberculosis Drug Market Trends
Table 105. Anti-Tuberculosis Drug Market Drivers
Table 106. Anti-Tuberculosis Drug Market Challenges
Table 107. Anti-Tuberculosis Drug Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-Tuberculosis Drug
Figure 2. Global Anti-Tuberculosis Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Anti-Tuberculosis Drug Market Share by Type in 2023 & 2030
Figure 4. First-Line Anti-Tuberculosis Drugs Product Picture
Figure 5. Second-Line Anti-Tuberculosis Drugs Product Picture
Figure 6. Global Anti-Tuberculosis Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Anti-Tuberculosis Drug Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Anti-Tuberculosis Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Anti-Tuberculosis Drug Market Size (2019-2030) & (US$ Million)
Figure 13. Global Anti-Tuberculosis Drug Sales (2019-2030) & (K Units)
Figure 14. Global Anti-Tuberculosis Drug Average Price (US$/Unit) & (2019-2030)
Figure 15. Anti-Tuberculosis Drug Report Years Considered
Figure 16. Anti-Tuberculosis Drug Sales Share by Manufacturers in 2023
Figure 17. Global Anti-Tuberculosis Drug Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Anti-Tuberculosis Drug Players: Market Share by Revenue in 2023
Figure 19. Anti-Tuberculosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Anti-Tuberculosis Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Anti-Tuberculosis Drug Sales Market Share by Country (2019-2030)
Figure 22. North America Anti-Tuberculosis Drug Revenue Market Share by Country (2019-2030)
Figure 23. United States Anti-Tuberculosis Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Anti-Tuberculosis Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Anti-Tuberculosis Drug Sales Market Share by Country (2019-2030)
Figure 26. Europe Anti-Tuberculosis Drug Revenue Market Share by Country (2019-2030)
Figure 27. Germany Anti-Tuberculosis Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Anti-Tuberculosis Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Anti-Tuberculosis Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Anti-Tuberculosis Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Anti-Tuberculosis Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Anti-Tuberculosis Drug Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Anti-Tuberculosis Drug Revenue Market Share by Region (2019-2030)
Figure 34. China Anti-Tuberculosis Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Anti-Tuberculosis Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Anti-Tuberculosis Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Anti-Tuberculosis Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Anti-Tuberculosis Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Anti-Tuberculosis Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Anti-Tuberculosis Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Anti-Tuberculosis Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Anti-Tuberculosis Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Anti-Tuberculosis Drug Sales Market Share by Country (2019-2030)
Figure 44. Latin America Anti-Tuberculosis Drug Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Anti-Tuberculosis Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Anti-Tuberculosis Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Anti-Tuberculosis Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Anti-Tuberculosis Drug Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Anti-Tuberculosis Drug Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Anti-Tuberculosis Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Anti-Tuberculosis Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Anti-Tuberculosis Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Anti-Tuberculosis Drug by Type (2019-2030)
Figure 54. Global Revenue Market Share of Anti-Tuberculosis Drug by Type (2019-2030)
Figure 55. Global Anti-Tuberculosis Drug Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Anti-Tuberculosis Drug by Application (2019-2030)
Figure 57. Global Revenue Market Share of Anti-Tuberculosis Drug by Application (2019-2030)
Figure 58. Global Anti-Tuberculosis Drug Price (US$/Unit) by Application (2019-2030)
Figure 59. Anti-Tuberculosis Drug Value Chain
Figure 60. Anti-Tuberculosis Drug Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
